scholarly article | Q13442814 |
P50 | author | Stephen W. Barthold | Q105872034 |
P2093 | author name string | A L Smith | |
D H Persing | |||
M S de Souza | |||
J L Janotka | |||
P2860 | cites work | The clinical evolution of Lyme arthritis | Q69415294 |
The histopathology of experimentally infected hamsters with the Lyme disease spirochete, Borrelia burgdorferi | Q70007719 | ||
Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles | Q70248294 | ||
Successful cultivation of spirochetes from skin lesions of patients with erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans | Q93587394 | ||
Isolation and cultivation of Lyme disease spirochetes | Q34258685 | ||
Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness | Q34541505 | ||
Reactivity of human Lyme borreliosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi. | Q34785002 | ||
Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice | Q35830458 | ||
Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization | Q36231714 | ||
Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B | Q36280937 | ||
Antibody response in white-footed mice (Peromyscus leucopus) experimentally infected with the Lyme disease spirochete (Borrelia burgdorferi). | Q37005786 | ||
Biochemical and immunological characterization of the surface proteins of Borrelia burgdorferi | Q37006636 | ||
Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals | Q37230094 | ||
Infection of Syrian hamsters with Lyme disease spirochetes. | Q37273661 | ||
Induction of lyme arthritis in LSH hamsters | Q40158709 | ||
Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency | Q43825498 | ||
Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease | Q44313259 | ||
Experimental chronic Lyme borreliosis in Lewis rats | Q45111148 | ||
Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. | Q53802786 | ||
Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. | Q54264896 | ||
Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis. | Q54287145 | ||
Lyme Disease | Q57485891 | ||
Recombination between genes encoding major outer surface proteins A and B of Borrelia burgdorferi | Q67983625 | ||
Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens | Q68053185 | ||
Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice | Q68184193 | ||
Lyme borreliosis in selected strains and ages of laboratory mice | Q68419839 | ||
Borrelia burgdorferi in joint fluid in chronic Lyme arthritis | Q68876235 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Lyme disease | Q201989 |
laboratory | Q483242 | ||
P304 | page(s) | 959-971 | |
P577 | publication date | 1993-09-01 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Chronic Lyme borreliosis in the laboratory mouse | |
P478 | volume | 143 |
Q35608499 | A family of genes located on four separate 32-kilobase circular plasmids in Borrelia burgdorferi B31. |
Q37117630 | A manganese transporter, BB0219 (BmtA), is required for virulence by the Lyme disease spirochete, Borrelia burgdorferi |
Q35543174 | A nonproliferating parvovirus vaccine vector elicits sustained, protective humoral immunity following a single intravenous or intranasal inoculation |
Q35557111 | Ablation of interleukin-12 exacerbates Lyme arthritis in SCID mice. |
Q36462764 | Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis |
Q33753858 | Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection |
Q39822919 | Adherence of Borrelia burgdorferi to the proteoglycan decorin |
Q35595529 | Agents of human anaplasmosis and Lyme disease at Camp Ripley, Minnesota |
Q33603276 | Altered stationary-phase response in a Borrelia burgdorferi rpoS mutant |
Q34975726 | Antibody-mediated disease remission in the mouse model of lyme borreliosis |
Q33615831 | Antigenic stability of Borrelia burgdorferi during chronic infections of immunocompetent mice |
Q37208398 | Assessment of transcriptional activity of Borrelia burgdorferi and host cytokine genes during early and late infection in a mouse model |
Q33827766 | Astrocytes produce IL-19 in response to bacterial challenge and are sensitive to the immunosuppressive effects of this IL-10 family member |
Q35551958 | B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis. |
Q41848529 | Bacterial heterogeneity is a requirement for host superinfection by the Lyme disease spirochete |
Q34601829 | Bgp, a secreted glycosaminoglycan-binding protein of Borrelia burgdorferi strain N40, displays nucleosidase activity and is not essential for infection of immunodeficient mice |
Q42613070 | Borrelia burgdorferi BmpA is a laminin-binding protein |
Q39164585 | Borrelia burgdorferi Manipulates Innate and Adaptive Immunity to Establish Persistence in Rodent Reservoir Hosts |
Q35947418 | Borrelia burgdorferi RevA Significantly Affects Pathogenicity and Host Response in the Mouse Model of Lyme Disease |
Q54917846 | Borrelia burgdorferi adhere to blood vessels in the dura mater and are associated with increased meningeal T cells during murine disseminated borreliosis. |
Q33296896 | Borrelia burgdorferi adhesins identified using in vivo phage display |
Q36588072 | Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector |
Q36446924 | Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis |
Q24561576 | Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses |
Q33361637 | Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity |
Q30839894 | Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity |
Q33748494 | Borrelia burgdorferi induces the production and release of proinflammatory cytokines in canine synovial explant cultures. |
Q39384177 | Borrelia burgdorferi infection induces lipid mediator production during Lyme arthritis |
Q43013530 | Borrelia burgdorferi organisms lacking plasmids 25 and 28-1 are internalized by human blood phagocytes at a rate identical to that of the wild-type strain |
Q35802349 | Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice |
Q34126051 | Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface |
Q36845153 | Borrelia burgdorferi vlsE antigenic variation is not mediated by RecA |
Q34478025 | Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells |
Q33828588 | BosR (BB0647) controls the RpoN-RpoS regulatory pathway and virulence expression in Borrelia burgdorferi by a novel DNA-binding mechanism |
Q39372859 | BosR (BB0647) governs virulence expression in Borrelia burgdorferi. |
Q34890094 | CD4+ T cells promote antibody production but not sustained affinity maturation during Borrelia burgdorferi infection |
Q34008784 | CD4+ T helper 1 cells facilitate regression of murine Lyme carditis |
Q35625493 | Characterization of cp18, a naturally truncated member of the cp32 family of Borrelia burgdorferi plasmids |
Q35415911 | Characterization of outer membranes isolated from Borrelia burgdorferi, the Lyme disease spirochete |
Q34290761 | Characterization of unique regions of Borrelia burgdorferi surface-located membrane protein 1. |
Q35417584 | Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi |
Q33753754 | Clearance of Borrelia burgdorferi may not be required for resistance to experimental lyme arthritis |
Q30874055 | Climate change and habitat fragmentation drive the occurrence of Borrelia burgdorferi, the agent of Lyme disease, at the northeastern limit of its distribution |
Q34007395 | Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis |
Q92658856 | Comparison of motif-based and whole-unique-sequence-based analyses of phage display library datasets generated by biopanning of anti-Borrelia burgdorferi immune sera |
Q33598183 | Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A. |
Q37510873 | Comparison of the lifetime host-to-tick transmission between two strains of the Lyme disease pathogen Borrelia afzelii |
Q39829393 | Complement-mediated serum sensitivity among spirochetes that cause Lyme disease. |
Q34008493 | Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies |
Q90287573 | Critical analysis of a doxycycline treatment trial of rhesus macaques infected with Borrelia burgdorferi |
Q37713266 | CsrA (BB0184) is not involved in activation of the RpoN-RpoS regulatory pathway in Borrelia burgdorferi |
Q33767776 | DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies |
Q27310842 | Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in mice |
Q32063131 | Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis |
Q34031718 | Delays and diversions mark the development of B cell responses to Borrelia burgdorferi infection |
Q35403982 | Dermal inflammation elicited by synthetic analogs of Treponema pallidum and Borrelia burgdorferi lipoproteins. |
Q39714043 | Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha |
Q35867594 | Detection of established virulence genes and plasmids to differentiate Borrelia burgdorferi strains |
Q37662663 | Diet-Induced Obesity Does Not Alter Tigecycline Treatment Efficacy in Murine Lyme Disease. |
Q33751384 | Different classes of proteoglycans contribute to the attachment of Borrelia burgdorferi to cultured endothelial and brain cells |
Q34424975 | Different patterns of expression and of IL-10 modulation of inflammatory mediators from macrophages of Lyme disease-resistant and -susceptible mice |
Q31158591 | Differential detection of five mouse-infecting helicobacter species by multiplex PCR |
Q36526375 | Differential spirochetal infectivities to vector ticks of mice chronically infected by the agent of Lyme disease |
Q24796731 | Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease |
Q34069819 | Dynamics of connective-tissue localization during chronic Borrelia burgdorferi infection |
Q35495721 | ELISA-based measurement of antibody responses and PCR-based detection profiles can distinguish between active infection and early clearance of Borrelia burgdorferi |
Q37352060 | Effect of anti-interleukin 12 treatment on murine lyme borreliosis |
Q33754842 | Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice |
Q37563638 | Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C. |
Q34005057 | Evidence for vaccine synergy between Borrelia burgdorferi decorin binding protein A and outer surface protein A in the mouse model of lyme borreliosis |
Q34535143 | Expression and gene sequence of outer surface protein C of Borrelia burgdorferi reisolated from chronically infected mice. |
Q37378706 | Feeding of ticks on animals for transmission and xenodiagnosis in Lyme disease research |
Q34007725 | Gamma interferon is not required for arthritis resistance in the murine Lyme disease model |
Q36932486 | Gene expression profiling provides insights into the pathways involved in inflammatory arthritis development: murine model of Lyme disease |
Q91900085 | Generality of Post-Antimicrobial Treatment Persistence of Borrelia burgdorferi Strains N40 and B31 in Genetically Susceptible and Resistant Mouse Strains |
Q34000974 | Genetic control of experimental lyme arthritis in the absence of specific immunity |
Q34606054 | Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto |
Q40374999 | Genetic stability of Borrelia burgdorferi recovered from chronically infected immunocompetent mice. |
Q37572365 | Genome-wide transposon mutagenesis of Borrelia burgdorferi for identification of phenotypic mutants |
Q35702808 | Heterogeneity of Borrelia burgdorferi Sensu Stricto Population and Its Involvement in Borrelia Pathogenicity: Study on Murine Model with Specific Emphasis on the Skin Interface |
Q34005799 | Homologous and heterologous Borrelia burgdorferi challenge of infection-derived immune rabbits using host-adapted organisms |
Q37592664 | Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for Borrelia miyamotoi |
Q41609395 | Host-pathogen interactions in the immunopathogenesis of Lyme disease |
Q42727236 | Human Lyme arthritis and the immunoglobulin G antibody response to the 37-kilodalton arthritis-related protein of Borrelia burgdorferi |
Q39746288 | Humoral Immunity Reflects Altered T Helper Cell Bias inBorrelia burgdorferi-Infected γδ T-Cell-Deficient Mice |
Q32063128 | Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice |
Q36060840 | Hyperglycemia Impairs Neutrophil-Mediated Bacterial Clearance in Mice Infected with the Lyme Disease Pathogen |
Q47097911 | Identification of Borrelia protein candidates in mouse skin for potential diagnosis of disseminated Lyme borreliosis |
Q35996715 | Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening |
Q34944212 | Immunogenicity of Borrelia burgdorferi arthritis-related protein |
Q33788181 | Immunoglobulin-regulated expression of Borrelia burgdorferi outer surface protein A in vivo |
Q35129412 | In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites. |
Q31157302 | Inactivation of genes for antigenic variation in the relapsing fever spirochete Borrelia hermsii reduces infectivity in mice and transmission by ticks |
Q33559321 | Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis |
Q33613691 | Ineffectiveness of tigecycline against persistent Borrelia burgdorferi |
Q34709026 | Influence of arthritis-related protein (BBF01) on infectivity of Borrelia burgdorferi B31. |
Q38575655 | Interferon-γ influences the composition of leukocytic infiltrates in murine lyme carditis |
Q35598063 | Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation |
Q48219438 | Intra- and interbacterial genetic exchange of Lyme disease spirochete erp genes generates sequence identity amidst diversity |
Q34739867 | Invasion of eukaryotic cells by Borrelia burgdorferi requires β(1) integrins and Src kinase activity |
Q37454001 | Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins |
Q37163689 | Live Attenuated Borrelia burgdorferi Targeted Mutants in an Infectious Strain Background Protect Mice from Challenge Infection |
Q37186506 | Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis |
Q34128445 | LuxS-mediated quorum sensing in Borrelia burgdorferi, the lyme disease spirochete |
Q26795774 | Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains? |
Q33597989 | Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein |
Q37001131 | Lyme arthritis: current concepts and a change in paradigm |
Q35764002 | Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B. |
Q35745605 | Macrophage Polarization during Murine Lyme Borreliosis. |
Q36784433 | Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis |
Q35465724 | Membrane protein variations associated with in vitro passage of Borrelia burgdorferi |
Q64053858 | Metamorphoses of Lyme disease spirochetes: phenomenon of Borrelia persisters |
Q35534616 | Molecular characterization of a 6.6-kilodalton Borrelia burgdorferi outer membrane-associated lipoprotein (lp6.6) which appears to be downregulated during mammalian infection. |
Q43230693 | MyD88 deficiency enhances acquisition and transmission of Borrelia burgdorferi by Ixodes scapularis ticks |
Q54708011 | Neotrombicula autumnalis (Acari, Trombiculidae) as a vector for Borrelia burgdorferi sensu lato? |
Q39449869 | One-step reverse transcriptase PCR method for detection of Borrelia burgdorferi mRNA in mouse Lyme arthritis tissue samples |
Q36576569 | OspB antibody prevents Borrelia burgdorferi colonization of Ixodes scapularis |
Q24614518 | OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands |
Q35902245 | Outer membrane proteins of pathogenic spirochetes |
Q21131613 | Outer surface protein B is critical for Borrelia burgdorferi adherence and survival within Ixodes ticks |
Q35465147 | P55, an immunogenic but nonprotective 55-kilodalton Borrelia burgdorferi protein in murine Lyme disease. |
Q33614007 | Passive immunizing activity of sera from mice infected with Borrelia burgdorferi |
Q36593814 | Persistence of Borrelia burgdorferi following antibiotic treatment in mice |
Q37417171 | Persistent arthritis in Borrelia burgdorferi-infected HLA-DR4-positive CD28-negative mice post-antibiotic treatment |
Q39511229 | Plasmin-coated borrelia Burgdorferi degrades soluble and insoluble components of the mammalian extracellular matrix |
Q41909299 | Presence of Arp specifically contributes to joint tissue edema associated with early-onset Lyme arthritis |
Q34296826 | Presence of multiple variants of Borrelia burgdorferi in the natural reservoir Peromyscus leucopus throughout a transmission season |
Q22242954 | Prospective study of serologic tests for lyme disease |
Q35103113 | Protective niche for Borrelia burgdorferi to evade humoral immunity |
Q35752911 | Rabbit model of Lyme borreliosis: erythema migrans, infection-derived immunity, and identification of Borrelia burgdorferi proteins associated with virulence and protective immunity |
Q42063094 | Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis |
Q33558655 | Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme disease |
Q37510608 | Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice |
Q36797128 | Review of evidence for immune evasion and persistent infection in Lyme disease |
Q42673332 | Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species |
Q39822441 | Single exposure of mice to Borrelia burgdorferi elicits immunoglobulin G antibodies characteristic of secondary immune response without production of interleukin-4 by immune T cells |
Q40081460 | Sleeper cells: the stringent response and persistence in the Borreliella (Borrelia) burgdorferi enzootic cycle. |
Q33999873 | Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato species |
Q30519448 | Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy |
Q39511009 | Stability of erp loci during Borrelia burgdorferi infection: recombination is not required for chronic infection of immunocompetent mice. |
Q39538113 | T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease |
Q47372972 | Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice |
Q35452406 | Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi |
Q37695366 | That's my story, and I'm sticking to it--an update on B. burgdorferi adhesins |
Q90604217 | The Lon-1 protease is required by Borrelia burgdorferi to infect the mammalian host |
Q35165125 | The absence of linear plasmid 25 or 28-1 of Borrelia burgdorferi dramatically alters the kinetics of experimental infection via distinct mechanisms |
Q36826979 | The early dissemination defect attributed to disruption of decorin-binding proteins is abolished in chronic murine Lyme borreliosis. |
Q36445104 | The luxS gene is not required for Borrelia burgdorferi tick colonization, transmission to a mammalian host, or induction of disease |
Q22252691 | The mammalian host response to borrelia infection |
Q36821318 | Therapeutic passive vaccination against chronic Lyme disease in mice |
Q37436773 | Understanding tropism and immunopathological mechanisms of relapsing fever spirochaetes |
Q33784565 | bptA (bbe16) is essential for the persistence of the Lyme disease spirochete, Borrelia burgdorferi, in its natural tick vector |
Search more.